Aqua Bio Technology — Share Issue/Capital Change 2024

Nov 12, 2024

AQUA BIO TECHNOLOGY ASA – SHARE CAPITAL INCREASE REGISTERED

12.11.2024 11:46:36 CET | Aqua Bio Technology ASA | Total number of voting rights and capital

Reference is made to the stock exchange announcement from Aqua Bio Technology ASA ("ABT" or the "Company") on 29 August 2024, regarding the Company's board of directors' resolution to issue a total of 5,000,000 new shares (the "New Shares") in connection with the settlement of the share component of the purchase price for ABT's acquisition of 3D Innovation Nordic AS.

The share capital increase pertaining to the issuance of the New Shares has today been registered with the Norwegian Register of Business Enterprises (Nw. Foretaksregisteret). ABT's new share capital is NOK 173,723,182.50 divided into 69,489,273 shares, each with a nominal value of NOK 2.50. The New Shares will be delivered on a separate ISIN pending publication of an EEA listing prospectus approved by the Norwegian Financial Supervisory Authority.

For further information, please contact Jan Varming, CFO, telephone +47 90 83 90 76.

This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Disclosure regulation

This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.

Contacts

Jan Aas Varming, CFO, Aqua Bio Technology ASA, +47 908 39 076, jan@aquabiotech.no

About Aqua Bio Technology ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable biotechnology for use in skin care products. ABT's cosmetics ingredients are highly effective and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing natural skin care products developed by partners towards consumers and professional users. Aqua Bio Technology is listed on Euronext Expand.

Attachments

Download announcement as PDF.pdf